TAC (TAC) 24-hour volatility reaches 50.3%: trading volume surge drives speculative rebound
Bitget Pulse2026/05/03 16:02Volatility Brief
In the past 24 hours, the price of TAC rebounded from a low of $0.019319 to a high of $0.029044, currently quoted at $0.025763, with a fluctuation amplitude of 50.3%. 24-hour trading volume expanded significantly to about $11.885 million, an explosive increase compared to regular levels.
Analysis of the Reason for the Abnormal Fluctuation
- Surge in trading volume: Bitget monitoring indicates that TAC trading volume rose sharply in the past 24 hours, driving a rebound from around $0.0168 to a high of $0.0243 and triggering speculative buying.
- There is no clear official announcement or on-chain large whale movement reported; the volatility is mainly driven by market speculative trading.
Market Views and Outlook
Market sentiment is predominantly short-term bullish, with Binance listing it among the top gainers of the day (+32.56%). Community discussions mention “pumping” and support near $0.00486. Future views focus on high volatility risks, and attention should be paid to the sustainability of the trading volume.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "Outlier" Investment Art in the New Era of Berky
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India
Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge
The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales
Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.
Crypto prices
More
